Serum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups

Sponsored by: Sengenics

19 +10pts

Speaker

Event Date & Time

Date: June 18, 2024

Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)

Abstract

Patients with rheumatoid arthritis (RA) can be categorized as either anti-citrullinated protein antibody-positive (ACPA+) or‍ negative (ACPA-). In this webinar, Dr. Sung will present his research exploring a broad range of serological autoantibodies to uncover immunological differences between these RA subgroups using data from ACPA+ RA patients, ACPA- RA patients, and matched‍ healthy controls.

Learning Objectives:

Learn how 1600+ IgG autoantibodies from serum were screened, yielding biologically relevant and immunologically significant insights.
Discover the distinct autoantibody profiles identified in ACPA+ and ACPA- patients.
Understand which proteins and their associated biological processes were predominantly targeted by these autoantibodies.
Explore the implications of autoantibody biomarkers in RA subgroups and their correlation with the Clinical Disease Activity Index, a measure of disease activity.
Examine how autoantibody biomarker signatures can enhance patient stratification and diagnostic accuracy in RA.

Webinars will be available for unlimited on-demand viewing after live event.

Serum Autoantibodies Differentiate Rheumatoid Arthritis Subgroups

Jaeyun Sung, PhD